Cytogenetics and molecular genetics of bladder cancer: A personal view
- 24 October 2002
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 115 (3), 173-182
- https://doi.org/10.1002/ajmg.10693
Abstract
The cytogenetic and molecular genetic aspects that may be involved in the pathogenesis of bladder cancer are presented. Although anomalies of chromosome 9 may play an initial causative role in this cancer, the subsequent events, involving a succession of genetic changes, are less established or understood. This presentation is a distillation of what generally are considered to be the cytogenetic and molecular genetic events that constitute the array of changes underlying bladder cancer.Keywords
This publication has 19 references indexed in Scilit:
- Functional Genomics, Gene Arrays, and the Future of PathologyLaboratory Investigation, 2001
- Molecular classification of cutaneous malignant melanoma by gene expression profilingNature, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression MonitoringScience, 1999
- Loss of Cell Cycle Regulators p27Kip1 and Cyclin E in Transitional Cell Carcinoma of the Bladder Correlates with Tumor Grade and Patient SurvivalThe American Journal of Pathology, 1999
- Cytogenetics of bladder cancerCancer Genetics and Cytogenetics, 1997
- A new approach in the diagnosis and follow-up of bladder cancerCancer Genetics and Cytogenetics, 1993
- Chromosomes in kidney, ureter, and bladder cancerCancer Genetics and Cytogenetics, 1986
- A possible specific chromosome change in transitional cell carcinoma of the bladderCancer Genetics and Cytogenetics, 1986
- Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasmsCancer, 1984